CoChat

Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; none of the 50 sources its claims cite is checked for support yet.

Abstract

Background: Influence of sarcopenia in combination with other body composition parameters and muscle strength on outcomes after oesophageal surgery for oesophageal cancer remains unclear. The objectives were (i) to describe the incidence of sarcopenia in relation to adipose tissue quantity and distribution and muscle strength; (ii) to evaluate if neoadjuvant chemoradiation (nCRTx) influences body composition and muscle strength; and (iii) to evaluate the influence of body composition and muscle strength on post‐operative morbidity and long‐term survival. Methods: This retrospective study included patients with oesophageal cancer who received nCRTx followed by surgery between January 2011 and 2016. Skeletal muscle, visceral, and subcutaneous adipose tissue cross‐sectional areas were calculated based on computed tomography scans, and muscle strength was measured using hand grip tests, 30 seconds chair stand tests, and maximal inspiratory and expiratory pressure tests prior to nCRTx and after nCRTx. Results: A total of 322 patients were included in this study. Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (P = 0.082). Patients with sarcopenia had a significantly lower muscle strength and higher fat percentage. The muscle strength and incidence of sarcopenia increased while the mean body mass index and fat percentage decreased during nCRTx. A body mass index above 25 kg/m 2 was associated with anastomotic leakage (P = 0.032). Other body composition parameters were not associated with post‐operative morbidity. A lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (P = 0.023 and P = 0.009, respectively). In multivariable analysis, a lower number of stands during the 30 seconds chair stand test prior to nCRTx (hazard ratio 0.93, 95% confidence interval 0.87–0.99, P = 0.017) and visceral adipose tissue of >128 cm 2 after nCRTx (hazard ratio 1.81, 95% confidence interval 1.30–2.53, P = 0.001) were associated with worse overall survival. Conclusions: Sarcopenia occurs frequently in patients with oesophageal cancer and is associated with less muscle strength and a higher fat percentage. Body composition changes during nCRTx did not influence survival. Impaired muscle strength and a high amount of visceral adipose tissue are associated with worse survival. Therefore, patients with poor fitness might benefit from preoperative nutritional and muscle strengthening guidance, aiming to increase muscle strength and decrease visceral adipose tissue. However, this should be confirmed in a large prospective study.

Overview

CoChat Summary

TL;DR

In 322 patients with oesophageal cancer treated with neoadjuvant chemoradiation (nCRTx) and surgery, sarcopenia was common (55.6% before and 58.2% after nCRTx) and associated with lower muscle strength and higher fat percentage, but not with post-operative morbidity or survival. Impaired muscle strength and high visceral adipose tissue after nCRTx were associated with worse overall survival.

Key findings

  • Sarcopenia was present in 55.6% of patients prior to nCRTx and 58.2% after nCRTx (P = 0.082). Patients with sarcopenia had significantly lower muscle strength and higher fat percentage; for example, after nCRTx, non-dominant handgrip strength was 37.5 ± 9.7 kg vs 44.6 ± 7.8 kg (P = 0.001), 30 s chair stand test was 16.6 ± 5.6 vs 22.1 ± 8.2 stands (P = 0.001), and fat percentage was 30.6 ± 4.5% vs 29.1 ± 5.4% (P = 0.017).
  • During nCRTx, the incidence of sarcopenia increased (55.6–58.2%, P = 0.082) while mean BMI and fat percentage decreased (−0.4 kg/m², 95% CI −0.3 to 0.5, P < 0.001; −0.6%, 95% CI −0.04 to 1.2, P = 0.036). All muscle strength tests increased; the strongest increases were maximal expiratory pressure (mean increase 9.4 cmH₂O, 95% CI 3.7–15.1, P = 0.001) and non-dominant handgrip strength (mean increase 1.4 kg, 95% CI 0.5–2.4, P = 0.004).
  • A BMI ≥26 kg/m² prior to nCRTx was associated with anastomotic leakage (15.9% of patients with BMI 18–25 kg/m² vs 26.0% with BMI ≥26 kg/m², P = 0.032). Lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (P = 0.023 and P = 0.009, respectively). Other body composition parameters were not associated with post-operative morbidity.
  • In multivariable analysis, a lower number of stands during the 30 s chair stand test prior to nCRTx (HR 0.93, 95% CI 0.87–0.99, P = 0.017) and visceral adipose tissue >128 cm² after nCRTx (HR 1.81, 95% CI 1.30–2.53, P = 0.001) were associated with worse overall survival. Sarcopenia itself was not significantly associated with survival (prior to nCRTx median overall survival 48.4 vs 31.8 months, P = 0.148; after nCRTx 37.6 vs 39.2 months, P = 0.805).

Methods

  • Retrospective study using a prospectively maintained database of consecutive patients with oesophageal cancer treated with surgery between 1 January 2011 and 1 January 2016 at Amsterdam UMC (location AMC), the Netherlands. Patients were included if they had resectable oesophageal carcinoma treated with nCRTx followed by surgery; exclusion criteria were missing or insufficient-quality diagnostic CT images before and after nCRTx. A total of 322 patients were included; in 175 patients, both CT scans prior to and after nCRTx were available and eligible for analysis.
  • Body composition was assessed from CT scans at the midpoint of the third lumbar vertebra (L3): skeletal muscle, visceral, subcutaneous, and total adipose tissue cross-sectional areas and indexes, presence of sarcopenia, body fat percentage, and BMI. Muscle strength was measured prior to and after nCRTx using hand grip tests, 30 s chair stand tests, and maximal inspiratory and expiratory pressure tests.
  • Statistical analysis included descriptive statistics, χ² or Fisher’s exact tests, Wilcoxon signed rank test, independent and dependent t-tests, Kaplan–Meier curves with log-rank tests, and Cox proportional hazard models for multivariable analysis with stepwise backwards elimination (P < 0.05 to stay in the model). Missing data were handled with complete case analysis; analyses used SPSS version 25.0, and two-sided P values <0.05 were considered significant.

Limitations

  • Stated in the paper: muscle strength was assessed only in patients also included in another study, and this subgroup was much smaller than the total cohort, which may have contributed to selection bias together with the retrospective design. The incidence of sarcopenic obesity was very low, so its influence on post-operative complications or long-term survival could not be assessed properly. Handgrip strength is less reliable in older patients, and the chair stand test can be influenced by co-morbidities; the cohort had a median age of 65 years and almost half had co-morbidities, which may have made muscle strength outcomes less reliable. No standardized cut-off values for sarcopenia exist; the study used Martin et al. cut-offs, which may differ from the Prado et al. population.
  • Evident from the text: this was a single-centre retrospective cohort, and missing data were handled with complete case analysis. Paired CT analyses were limited to 175 of 322 patients who had both pre- and post-nCRTx CT scans available and eligible for analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/jcsm.12540

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flowchart patient selection. Insufficient quality for measurements includes the following: Tissue was cut off from the frame, and/or the CT scan was not in portal phase, and/or it was not a high‐resolution scan. CT, computed tomography; nCRTx, neoadjuvant chemoradiation.
Figure 1 Flowchart patient selection. Insufficient quality for measurements includes the following: Tissue was cut off from the frame, and/or the CT scan was not in portal phase, and/or it was not a high‐resolution scan. CT, computed tomography; nCRTx, neoadjuvant chemoradiation.CC BY-NC-ND · PubMed Central
Figure 2 Influence of body composition and muscle strength on post‐operative complications. T0 is prior to neoadjuvant therapy, and T1 is after neoadjuvant therapy and prior to surgery.
Figure 2 Influence of body composition and muscle strength on post‐operative complications. T0 is prior to neoadjuvant therapy, and T1 is after neoadjuvant therapy and prior to surgery.CC BY-NC-ND · PubMed Central
Figure 3 Kaplan–Meier survival curves. Change in fat percentage defined as at least 2% change, change in BMI defined as at least 1 unit change, change in skeletal muscle index defined as at least 1.5 cm2/m2 change. P values based on log‐rank test. BMI, body mass index; nCRTx, neoadjuvant chemoradiation.
Figure 3 Kaplan–Meier survival curves. Change in fat percentage defined as at least 2% change, change in BMI defined as at least 1 unit change, change in skeletal muscle index defined as at least 1.5 cm2/m2 change. P values based on log‐rank test. BMI, body mass index; nCRTx, neoadjuvant chemoradiation.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 32 Not checked · 57 Own results and interpretations

49 more claims

Create a free account to see all 89 claims and to verify the 48 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 8 · the rest aren’t loaded

3 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Boer Maureen M, 2011, Herziene richtlijn ‘Oesofaguscarcinoom’, Ned Tijdschr Geneeskd, 155, A3732

Cited by

See all 65

Metadata

Authors
Hagens, E. R. C., Feenstra, M. L., van Egmond, M. A., van Laarhoven, H. W. M., Hulshof, M. C. C. M., Boshier, P. R., Low, D. E., van Berge Henegouwen, M. I., & Gisbertz, S. S.
Affiliations
  • Amsterdam University Medical Centers (NL)
  • Virginia Mason Medical Center (US)
  • Department of Surgery Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands
Corresponding author
Gisbertz, Suzanne S.
Venue
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Published
2020-02-25
Volume
11
Issue
3
Pages
756-767
ISSN
  • 2190-5991 (ISSN-L)
  • 2190-6009
OpenAlex
W3007363454
Cited by
65
References
55
Citations by year
2026: 13 · 2025: 9 · 2024: 13 · 2023: 6 · 2022: 17 · 2021: 5 · 2020: 2
FWCI
4.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Cachexia Sarcopenia and Muscle (publishedVersion, cc-by-nc-nd)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Cancer Research UK (27981)
  • National Institute for Health and Care Research (ACF-2014-21-007, CL-2017-21-005)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords
esophageal cancer, sarcopenia, body composition, muscle strength, neoadjuvant chemoradiotherapy, visceral adipose tissue, subcutaneous adipose tissue, grip strength, chair stand test, anastomotic leakage, postoperative morbidity, overall survival, body mass index, esophagectomy, skeletal muscle area, maximal inspiratory pressure
MeSH terms
Body Composition, Esophageal Neoplasms, Female, Humans, Middle Aged, Retrospective Studies, Treatment Outcome, Muscle Strength

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment. https://app.cochat.ai/papers/10.1002/jcsm.12540
The paper
Hagens, E. R. C., Feenstra, M. L., van Egmond, M. A., van Laarhoven, H. W. M., Hulshof, M. C. C. M., Boshier, P. R., Low, D. E., van Berge Henegouwen, M. I., & Gisbertz, S. S. (2020). Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.12540

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.